Ledger.Open graph →
SEC Form D · filed March 2, 2018

BRADMER PHARMACEUTICALS INC

Offering
$38.5M
Sold
$38.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Toronto, Ontario, Canada
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Alan Ezrin · Lexington, KYExec · DirectorDale Boden · Louisville, KYDirectorRobert Tessarolo · Oakville, Ontario, CanadaDirectorChuck Lilly · Sudbury, Ontario, CanadaDirectorPaul Van Damme · Edmonton, Alberta, CanadaExecAlan Ezrin · Lexington, KYExec · DirectorRobert Tessarolo · Oakville, Ontario, CanadaDirectorChuck Lilly · Sudbury, Ontario, CanadaDirectorDale Boden · Louisville, KYDirectorPaul Van Damme · Edmonton, Alberta, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗